People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.
After the third day of squirting an experimental drug up his nose, Dylan Meetze felt…
People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.
After the third day of squirting an experimental drug up his nose, Dylan Meetze felt horrible. “It was like I was underwater, like it took the most to do anything,” he said. Meetze stopped taking the drug but endured fatigue and anxiety for months afterward, and his eyes and muscles twitched, he said. He had…
Fears About Kids’ Online Safety Unite Democrats and Republicans
The U.S. Senate candidates in Texas could hardly be more different: James Talarico, a former seminarian turned Democratic state lawmaker who speaks in calm cadences about love and empathy, and Ken Paxton, the pugnacious Republican state attorney general who speaks about a refusal to compromise. They share an enemy, though. They dislike social media’s effects…
The Sometimes-Awkward Art of Asking for a Second Opinion
When Carol Daniel, a veteran broadcast journalist who lives near St. Louis, was diagnosed with thyroid cancer in 2022, her husband encouraged her to seek a second opinion. She was worried that consulting another doctor might seem like a betrayal. Daniel said she wondered: “Am I cheating on him? Am I going behind his back?…
AI in Health Care: Who Gets Left Behind?
Health care’s AI future is being built right now. The open question is “for whom?” Dr. Uché Blackstock — emergency physician, former associate professor at NYU School of Medicine, founder and CEO of Advancing Health Equity, and author of The New York Times bestseller “Legacy: A Black Physician Reckons with Racism in Medicine” — joins…
Healthix HIE Plays Role in N.Y.’s Efforts to Meet Medicaid Work Rule Requirements
HIE is creating dashboards to identify who’s most at risk of losing coverage and who might fall into the exemption categories
Employers that exclude GLP-1s point staff to a website and a pretax account
By JOHN SAMARAS Most employers still won’t cover GLP-1s for weight loss, and some of them now tell the employee where to buy them without the plan. The International Foundation of Employee Benefit Plans’ 2026 survey, published in July, found that 60 percent of employers cover the drugs for diabetes only and 36 percent for…
CMS, GAO Reports Offer Early Look at Rural Health Funding and Oversight
New reports examine state spending, progress and oversight
Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug
Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug appeared first on MedCity News.
Outro Raises $7M To Support Safe Deprescribing
Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures. The post Outro Raises $7M To Support Safe Deprescribing appeared first on MedCity News.
Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem
Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make. The post Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem appeared first on MedCity News.
